Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmaxim Enterprises AB
AB
Dissolved
Org 5568622707
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2011 · 14 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Pharmaxim Enterprises AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
34M
25M
17M
8M
0M
2019: 22M
22M
2019
2020: 27M (+23% vs 2019)
27M
+23%
2020
2021: 19M (-30% vs 2020)
19M
-30%
2021
2022: 22M (+16% vs 2021)
22M
+16%
2022
2023: 6M (-73% vs 2022)
6M
-73%
2023
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
Income statement
SEK thousands
Item
2023
2022
2021
2020
2019
Revenue
6 235
21 608
19 342
27 134
21 967
Staff expenses
—
—
—
—
—
EBITDA
−122
−8
4
8
2
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−122
−8
4
8
2
Net financials
235
14
—
−1
−1
Profit before tax
26
6
4
8
1
Tax
1
−1
−3
−7
−0
Net profit
27
5
1
1
1
Balance sheet
SEK thousands
Item
2023
2022
2021
2020
2019
Total assets
391
9 146
8 028
12 382
7 940
Equity
276
250
245
243
243
Long-term debt
0
0
0
0
0
Short-term debt
115
8 897
7 783
12 139
7 697
Total debt
115
8 897
7 783
12 139
7 697
Financial ratios
5-year trend
EBITDA margin
−2,0 %
This company
15,8 %
Market median
This company
Market median
113% below market
2019
2023
Equity ratio
70,6 %
This company
38,2 %
Market median
This company
Market median
85% above market
2019
2023
Return on equity
9,8 %
This company
18,4 %
Market median
This company
Market median
47% below market
2019
2023
Net profit margin
0,4 %
This company
8,1 %
Market median
This company
Market median
95% below market
2019
2023
Asset turnover
15,95×
This company
1,12×
Market median
This company
Market median
>999% above market
2019
2023
Debt / equity
0,42×
This company
0,62×
Market median
This company
Market median
32% below market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
More on Pharmaxim Enterprises AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
